DOCSLIB.ORG

Cornea Subspecialty Day 2019 Keeping Disease at Bay

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Cornea Subspecialty Day 2019 Keeping Disease at Bay Cornea Subspecialty Day 2019 Keeping Disease at Bay Program Directors Jennifer Y Li MD, Sanjay V Patel MD FRCOphth, and Sophie X Deng MD PhD In conjunction with the Cornea Society Moscone Convention Center San Francisco, CA Saturday, Oct. 12, 2019 Presented by: The American Academy of Ophthalmology Cover photo courtesy of Sophie X Deng MD PhD Supported by an unrestricted educational grant from Dompé. 2019 Cornea Planning Group 2014 William Barry Lee MD Subspecialty Day Advisory Committee Jennifer Y Li MD Elmer Y Tu MD Daniel S Durrie MD Program Director Stephen C Kaufman MD PhD Associate Secretary Sanay V Patel MD FRCOphth 2013 Kathryn A Colby MD PhD Julia A Haller MD Program Director William Barry Lee MD Michael S Lee MD Elmer Y Tu MD Shahzad I Mian MD Sophie X Deng MD PhD 2012 Anthony J Aldave MD Program Director R Michael Siatkowski MD Natalie A Afshari MD Kuldev Singh MD Kathryn A Colby MD PhD Former Program Directors 2011 Christopher J Rapuano MD Maria M Aaron MD 2018 Carol L Karp MD Natalie A Afshari MD Secretary for Annual Meeting Jennifer Y Li MD Anthony J Aldave MD Sanay V Patel MD FRCOphth 2010 Michael W Belin MD Staff 2017 Bennie H Jeng MD David B Glasser MD Melanie R Rafaty CMP, Director, Scientific Carol L Karp MD Christopher J Rapuano MD Meetings Jennifer Y Li MD 2008 Michael W Belin MD Ann L’Estrange, Subspecialty Day Manager 2016 Shahzad I Mian MD David B Glasser MD Debra Rosencrance CMP CAE, Vice Bennie H Jeng MD Mark J Mannis MD President, Meetings & Exhibits Carol L Karp MD 2007 Michael W Belin MD Patricia Heinicke Jr, Copy Editor 2015 Stephen C Kaufman MD PhD David B Glasser MD Mark Ong, Designer Bennie H Jeng MD R Doyle Stulting MD PhD Gina Comaduran, Cover Design Shahzad I Mian MD ©2019 American Academy of Ophthalmology. All rights reserved. No portion may be reproduced without express written consent of the American Academy of Ophthalmology. ii Planning Group 2019 Subspecialty Day | Cornea 2019 Cornea Subspecialty Day Planning Group On behalf of the American Academy of Ophthalmology and the Cornea Society, it is our pleasure to welcome you to San Francisco and Cornea Subspecialty Day 2019: Keeping Disease at Bay. Jennifer Y Li MD Sanjay V Patel MD FRCOphth Sophie X Deng MD PhD Program Director Program Director Program Director None None California Institute for Regenerative Medicine: S National Eye Institute, Inc.: S Kowa Research Institute, Inc.: C W L Gore & Associates: C 2019 Subspecialty Day | Cornea Planning Group iii 2019 Subspecialty Michael S Lee MD AAO Staff (Neuro-Ophthalmology) Day Advisory Evolvemed: C Ann L’Estrange National Eye Institute: S None Committee Quark Pharmaceuticals: S Springer: P Daniel S Durrie MD, Chair Melanie Rafaty UptoDate: P (Refractive Surgery) None Vindico: C AcuFocus, Inc.: C,O Alcon Laboratories, Inc.: C Debra Rosencrance Alphaeon: O Shahzad I Mian MD (Cornea) None National Eye Institute: S Avedro: C,L,O Concierge Key Health: O,C Beth Wilson Eyegate Pharma: C R Michael Siatkowski MD None Hoopes Durrie Rivera Research (Pediatric Ophthalmology) None Center: C iOR Holdings: O iOR Partners: O Kuldev Singh MD Johnson & Johnson Vision: C,L (Glaucoma) Aerie: C Strathspey Crown LLC: O Aerpio: C Alcon Laboratories, Inc.: C Maria M Aaron MD Allergan: C (Secretary for Annual Belkin Laser Ltd.: C Meeting) Glaukos Corp.: C None Graybug: C InjectSense: C Julia A Haller MD (Retina) Ivantis: C Aura Biosciences: C Johnson & Johnson: C Celgene: O Mynosys: C KalVista: C National Eye Institute: S Lowy Medical Research Novartis Institute for Biomedical Institute: C Research: C Novartis Pharmaceuticals Ocular Therapeutix, Inc.: C Corp.: C Santen, Inc.: C Shire: C Thieme Medical Publishers: C U.S. Food and Drug Administration: C,S 2019 Subspecialty Day | Cornea Contents v Cornea 2019 Contents Cornea 2019 Subspecialty Day Planning Group ii CME vi Faculty Listing viii How to Use the Audience Interaction Application xii Program Schedule xiii Section I: Bent Out of Shape—Ectasia Update 1 Section II: Dry Eye/Ocular Surface Disease 11 Are You AT the Table or ON the Menu? 22 Section III: Infectious Keratitis 24 Section IV: Keratoplasty and Keratoprosthesis 32 Section V: Anterior Segment Tumors 41 Section VI: Inflammatory Diseases of the Cornea 51 Faculty Financial Disclosure 59 Presenter Index 62 vi CME Credit 2019 Subspecialty Day | Cornea CME Credit Academy’s CME Mission Statement Control of Content The purpose of the American Academy of Ophthalmology’s The American Academy of Ophthalmology considers present- Continuing Medical Education (CME) program is to present ing authors, not coauthors, to be in control of the educational ophthalmologists with the highest quality lifelong learning content. It is Academy policy and traditional scientific publish- opportunities that promote improvement and change in physi- ing and professional courtesy to acknowledge all people con- cian practices, performance, or competence, thus enabling such tributing to the research, regardless of CME control of the live physicians to maintain or improve the competence and profes- presentation of that content. This acknowledgement is made in sional performance needed to provide the best possible eye care a similar way in other Academy CME activities. Though they for their patients. are acknowledged, coauthors do not have control of the CME content and their disclosures are not published or resolved. 2019 Cornea Subspecialty Day Meeting Learning Objectives 2019 Cornea Subspecialty Day CME Credit Upon completion of this activity, participants should be able to: The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education ■ Understand current best practices for the management of (ACCME) to provide CME for physicians. corneal infections The Academy designates this live activity for a maximum ■ Discuss the role of keratoplasty in the management of of 7 AMA PRA Category 1 Credits™. Physicians should claim patients with corneal disease only the credit commensurate with the extent of their participa- ■ Understand the role of imaging and in-office diagnostics tion in the activity. in the treatment of corneal disorders ■ Provide a rationale for treatment of dry eye and other ocular surface diseases and inflammatory disorders Attendance Verification for CME Reporting ■ List management strategies for patients with keratoconus Before processing your requests for CME credit, the Academy must verify your attendance at AAO 2019 and/or Subspecialty 2019 Cornea Subspecialty Day Meeting Target Day. Badges are no longer mailed before the meeting. Picking up Audience your badge onsite will verify your attendance. The intended audience for this program is cornea surgeons, comprehensive ophthalmologists with an interest in anterior Badge Scanning and CME segment, and allied health personnel who are performing or Getting your badge scanned does not automatically grant CME assisting with cornea surgery. credit. You still need to record your own educational activities. NOTE: You should claim only the credit commensurate with Teaching at a Live Activity the extent of your participation in the activity. Teaching instruction courses or delivering a scientific paper or poster is not an AMA PRA Category 1 Credit™ activity and CME Credit Reporting should not be included when calculating your total AMA PRA Onsite, report credits earned during Subspecialty Day and/or Category 1 Credits™. Presenters may claim AMA PRA Cat- AAO 2019 at CME Credit Reporting kiosks located in South egory 1 Credits™ through the American Medical Association. Lobby, West Lobby, and in the Academy Resource Center, West To obtain an application form please contact the AMA at Booth 7337. www.ama-assn.org. Registrants whose attendance is verified at AAO 2019 will receive an email on Monday, Oct. 14, with a link and instruc- Scientific Integrity and Disclosure of Conflicts of tions on how to claim credit online. Attendees can use this link Interest to report credits until Wednesday, Oct. 30. Starting Thursday, Nov. 14, attendees can claim credits The American Academy of Ophthalmology is committed to online through the Academy’s CME web page, aao.org/ ensuring that all continuing medical education (CME) informa- cme-central. tion is based on the application of research findings and the implementation of evidence-based medicine. It seeks to promote balance, objectivity, and absence of commercial bias in its content. All persons in a position to control the content of this activity must disclose any and all financial interests. The Acad- emy has mechanisms in place to resolve all conflicts of interest prior to an educational activity being delivered to the learners. 2019 Subspecialty Day | Cornea CME Credit vii Academy Members Proof of Attendance The CME credit reporting receipt is not a CME transcript. The following types of attendance verification are available dur- CME transcripts that include AAO 2019 credits entered at the ing AAO 2019 and Subspecialty Day for those who need it for American Academy of Ophthalmology’s annual meeting will reimbursement or hospital privileges, or for nonmembers who be available to Academy members through the Academy’s CME need it to report CME credit: web page beginning Thursday, Nov. 14. ■ CME credit reporting/proof-of-attendance letters The Academy transcript cannot list individual course atten- ■ Onsite registration receipt dance. It will list only the overall credits claimed for educational ■ Instruction course and session verification activities at Subspecialty Day and/or AAO 2019. You must have obtained your proof of attendance at the CME Credit Reporting kiosks onsite located in South Lobby, West Nonmembers Lobby, and in the Academy Resource Center, West Booth 7337. The American Academy of Ophthalmology provides nonmem- bers with verification of credits earned and reported for a single Academy-sponsored CME activity. To obtain a printed record of your credits, claim CME credits onsite at the CME Credit Reporting kiosks.
Load more

Recommended publications
  • Intraoperative Optical Coherence Tomography Imaging in Corneal Surgery: a Literature Review and Proposal of Novel Applications
    Hindawi Journal of Ophthalmology Volume 2020, Article ID 1497089, 10 pages https://doi.org/10.1155/2020/1497089 Research Article Intraoperative Optical Coherence Tomography Imaging in Corneal Surgery: A Literature Review and Proposal of Novel Applications Hiroshi Eguchi ,1 Fumika Hotta,1 Shunji Kusaka,1 and Yoshikazu Shimomura2 1Department of Ophthalmology, Kindai University, Faculty of Medicine, 377-2 Ohnohigashi, Osakasayama, Osaka 589-8511, Japan 2Department of Ophthalmology, Fuchu Eye Center, 1-10-17 Hiko-cho, Izumi, Osaka 594-0076, Japan Correspondence should be addressed to Hiroshi Eguchi; [email protected] Received 26 June 2020; Revised 12 August 2020; Accepted 21 August 2020; Published 11 September 2020 Academic Editor: Sang Beom Han Copyright © 2020 Hiroshi Eguchi et al. &is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Intraoperative optical coherence tomography (iOCT) is widely used in ophthalmic surgeries for cross-sectional imaging of ocular tissues. &e greatest advantage of iOCTis its adjunct diagnostic efficacy, which facilitates to decision-making during surgery. Since the development of microscopic-integrated iOCT (MIOCT), it has been widely used mainly for vitreoretinal and anterior segment surgeries. In corneal transplantation, MIOCT allows surgeons to visualise structure underneath the turbid and distorted cornea, which are impossible to visualise with a usual microscope. Real-time visualisation of hard-to-see area reduces the operation time and leads to favorable surgical outcomes. &e use of MIOCT is advantageous for a variety of corneal surgical procedures. Here, we have reviewed articles focusing on the utility of iOCT and MIOCTin penetrating keratoplasty, deep anterior lamellar keratoplasty, Descemet stripping automated endothelial keratoplasty, and Descemet membrane endothelial keratoplasty.
    [Show full text]
  • Olivia Steinberg ICO Primary Care/Ocular Disease Resident American Academy of Optometry Residents Day Submission
    Olivia Steinberg ICO Primary Care/Ocular Disease Resident American Academy of Optometry Residents Day Submission The use of oral doxycycline and vitamin C in the management of acute corneal hydrops: a case comparison Abstract- We compare two patients presenting to clinic with an uncommon complication of keratoconus, acute corneal hydrops. Management of the patients differs. One heals quickly, while the other has a delayed course to resolution. I. Case A a. Demographics: 40 yo AAM b. Case History i. CC: red eye, tearing, decreased VA x 1 day OS ii. POHx: (+) keratoconus OU iii. PMHx: depression, anxiety, asthma iv. Meds: Albuterol, Ziprasidone v. Scleral CL wearer for approximately 6 months OU vi. Denies any pain OS, denies previous occurrence OU, no complaints OD c. Pertinent Findings i. VA cc (CL’s)- 20/25 OD, 20/200 PH 20/60+2 OS ii. Slit Lamp 1. Inferior corneal thinning and Fleisher ring OD, central scarring OD, 2+ diffuse microcystic edema OS, Descemet’s break OS (photos and anterior segment OCT) 2. 2+ diffuse injection OS 3. D&Q A/C OU iii. Intraocular Pressures: deferred OD due to CL, 9mmHg OS (tonopen) iv. Fundus Exam- unremarkable OU II. Case B a. Demographics: 39 yo AAM b. Case History i. CC: painful, red eye, tearing, decreased VA x 1 day OS ii. POHx: unremarkable iii. PMHx: hypertension iv. Meds: unknown HTN medication v. Wears Soflens toric CL’s OU; reports previous doctor had difficulty achieving proper fit OU; denies diagnosis of keratoconus OU vi. Denies any injury OS, denies previous occurrence OU, no complaints OD c.
    [Show full text]
  • Painless Presentation of Acute Hydrops in Keratoconus with Serial In-Vivo Imaging
    Painless Presentation of Acute Hydrops in Keratoconus with Serial In-vivo Imaging Sara Berke-Silva, O.D. and Kimberly Reed, O.D. Nova Southeastern University Abstract Acute corneal hydrops is typically associated with acute pain, photophobia, and tearing at onset, but our patient denied these symptoms. The poster will present this case and review current diagnostic and therapeutic strategies, including controversies. I. Case History a. 21 year old Hispanic female b. The patient woke up 3 hours prior to examination with an acute onset of a ‘white spot’ and reduced vision OD. Denies pain, photophobia, tearing. c. After further questioning, the patient reported foreign body sensation OU that was unchanged from the normal amount she experiences without her contact lenses. d. Diagnosed with Keratoconus at age 15. Wore corneal RGPs until two years ago when semi-scleral lenses were employed with excellent visual outcomes. II. Pertinent Findings a. The patient was not photophobic and denied pain throughout the exam. Increased lacrimation was evident, unbeknownst to the patient. b. Slit lamp examination revealed significant corneal edema centrally with an absence of an anterior chamber reaction. Epithelial bullae were present. c. OCT confirmed posterior corneal compromise and significant corneal edema throughout all layers, with several bullae and microcysts in the epithelium. III. Differential Diagnosis a. Hydrops b. Corneal abrasion caused by contact lens wear c. Corneal edema caused by contact lens overwear d. Corneal infection causing ulceration e. Acute, severe corneal edema due to other cause of endothelial failure IV. Diagnosis and Discussion a. Acute corneal hydrops in the context of keratoconus has typically been associated with pain, photophobia, and tearing at onset (1,2,3), but our patient denied having these symptoms.
    [Show full text]
  • Acute Keratoconus-Like Corneal Hydrops Secondary to Ocular
    perim Ex en l & ta a l ic O p in l h Journal of Clinical & Experimental t C h f a o l m l a o Ke et al., J Clin Exp Ophthalmol 2017, 8:6 n l o r g u y o Ophthalmology J DOI: 10.4172/2155-9570.1000694 ISSN: 2155-9570 Case Report Open Access Acute Keratoconus-Like Corneal Hydrops Secondary to Ocular Massage Following Trabeculectomy Hongmin Ke, Chengguo Zuo and Mingkai Lin* State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, 54 Xianlie Nan Road, Guangzhou, China *Corresponding author: Mingkai Lin, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, 54 Xianlie Nan Road, Guangzhou, China, 510060, E- mail: [email protected] Received date: November 13, 2017; Accepted date: November 21, 2017; Published date: November 23, 2017 Copyright: © 2017 Ke H, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Purpose: To report a case of acute keratoconus-like corneal hydrops in a patient with long-term ocular massage following trabeculectomy. Methods: Case report and review of medical literature. Results: A rare complication of acute keratoconus-like corneal hydrops occurred in a patient following the use of ocular massage to maintain satisfactory aqueous humor filtration after trabeculectomy. The patient had a history of high myopia but denied previous ocular trauma, allergic disease and a family history of keratoconus. Slit-lamp examination demonstrated keratoconus-like corneal hydrops with formation of epithelial microcystic, and intrastromal cleft.
    [Show full text]
  • Molly Smith I. Case History a 28 Year Old White Male Presented to The
    Molly Smith Abstract: A 28 year-old white male with keratoconus OU presents with cloudy vision OS for 1 day. His diagnosis is acute hydrops and treatment includes Pred Forte and Vigamox QID with 2 day follow up. I. Case History A 28 year old white male presented to the clinic complaining of gradual onset cloudy/blurred vision OS for one day. He was asymptomatic for pain or photophobia. This patient’s ocular history included keratoconus OD<OS since 2006 with mild contact lens related dry eye. His personal medical history was positive for chronic migraines with aura, anxiety, kidney stones and chronic allergies. This patient’s medications included Zoloft, Lamictal, Excedrin migraine, and buspirone. II. Pertinent findings The patient’s uncorrected entrance visual acuities were 20/200 OD, which improved to 20/100 with pinhole, and 20/800 OS, which improved to 20/250 with pinhole. This pinhole visual acuity OS was reduced compared to his previous comprehensive exam two weeks prior, where his pinhole visual acuity was 20/150 OS. Slit lamp exam OD revealed trace conjunctival injection with mild linear scars in the central cornea. Upon examination OS, the central cornea appeared cloudy and hazy with significant edema. There were areas of cystic change around 1 and 7 o’clock approximately 1-2 mm in size along with smaller, more diffuse areas of microcystic changes throughout the central cornea. View of the anterior chamber was difficult to attain due to haze, but looking through the superior cornea with patient in down gaze revealed no cells or flare.
    [Show full text]
  • Corneal Blindness in Plato's Cave: the Acting Forces to Prevent and Revert
    A RQUIVOS B RASILEIROS DE REVIEW ARTICLE Corneal blindness in Plato’s cave: the acting forces to prevent and revert corneal opacity. Part I: epidemiology and new physiopathological concepts A cegueira corneal na caverna de Platão: as forças para prevenir e reverter a opacidade da córnea. Parte I: epidemiologia e novos conceitos na fisiopatologia Amanda Pires Barbosa1, Monica Alves2 , João Marcello Fortes Furtado1, Leidiane Adriano1 , Luis Fernando Nominato1, Lara Cristina Dias1, Marina Zilio Fantucci1, Adriana de Andrade Batista Murashima1, Eduardo Melani Rocha1 1. Research Core in Ocular Physiopathology and Therapeutics and Department of Ophthalmology, Otorhinolaryngology and Head & Neck Surgery, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil. 2. Department of Ophthalmology and Otorhinolaryngology, Faculdade de Ciências Médicas, Universidade Estadual de Campinas, Campinas, SP, Brazil. ABSTRACT | The burden of corneal blindness and visual de mais de 16 milhões de pessoas. A associação com várias deficiency can be felt worldwide. Its association with several doenças endêmicas, como cegueira infantil, trauma, ceratites endemic diseases such as childhood blindness, trauma, infecciosas (incluindo herpes, hanseníase e fungos), hipovita- infectious keratitis (including variants caused by herpes, minose A, diabetes mellitus e outras causas de síndromes de hanseniasis, and fungi), vitamin A deficiency, diabetes mellitus, olho seco, indicam que a verdadeira frequência é subestimada and other dry eye syndromes reflects its poorly understood e que os diferentes mecanismos são pouco conhecidos. A baixa underlying mechanisms and suggests that the actual frequency eficácia na prevenção e tratamento da cicatriz e deformidade of the disease is underestimated. The low effectiveness of da córnea permite antecipar que a prevalência da cegueira preventive and therapeutic strategies against corneal scarring corneal irá crescer no futuro.
    [Show full text]
  • Corneal Hydrops in Keratoconus 1Prafulla K Maharana, 2Ritu Nagpal, 3Namrata Sharma
    IJKECD Prafulla K Maharana et al 10.5005/jp-journals-10025-1098 REVIEW ARTICLE Corneal Hydrops in Keratoconus 1Prafulla K Maharana, 2Ritu Nagpal, 3Namrata Sharma ABSTRACT marginal corneal degeneration (PMCD), keratoglobus and 1 Purpose: The purpose of this review is to outline the etiology, Terrien’s marginal degeneration (TMD). The reported clinical features, and management of acute corneal hydrops incidence ranges from 2.6 to 35%.2 (CH) in cases of keratoconus (KC). Recent findings:The advent of newer investigative modalities Epidemiology and Risk Factors like ultra biomicroscopy, anterior segment optical coherence tomography and confocal microscopy has contributed toward Risk factors for CH include young age, male sex, poor the diagnosis, treatment planning and following the course of visual acuity at presentation, steep keratometry,2 therapy in cases of acute hydrops. severe ectasia at presentation,5 eccentric cone location,6 7 8 Summary: Corneal hydrops is an acute complication of co-existent vernal keratoconjunctivitis, down syndrome, keratoconus which in most instances resolves spontaneously. congenital rubella,9 corneal microtrauma due to repeated However, prolonged corneal edema can lead to complications, eye rubbing. Among all associated factors eye rubbing is such as corneal neovascularization which can jeopardise a 3 future corneal graft. Hence, timely intervention is required the most important risk factor. in most cases to prevent such complications as well as for early visual rehabilitation. Intracameral gas injection is the Natural History of Corneal Hydrops most commonly performed surgical procedure for hydrops. Modifications in surgical technique can help to tackle difficult Acute hydrops develops when the DM of ectatic cornea situations.
    [Show full text]
  • Acute Corneal Hydrops in Down Syndrome Shinji Makino* Department of Ophthalmology, Jichi Medical University, Shimotsuke, 3311-1 Yakushiji, Tochigi 329-0498, Japan
    ical C lin as Makino, J Clin Case Rep 2012, 2:17 C e f R o l e a p DOI: 10.4172/2165-7920.1000235 n o r r t u s o J Journal of Clinical Case Reports ISSN: 2165-7920 Case Report Open Access Acute Corneal Hydrops in Down Syndrome Shinji Makino* Department of Ophthalmology, Jichi Medical University, Shimotsuke, 3311-1 Yakushiji, Tochigi 329-0498, Japan Abstract We report a case of severe acute corneal hydrops in a 32-year-old woman with keratoconus associated with Down syndrome. The anterior segment of her right eye showed an extremely diffuse edematous ectasia of acute corneal hydrops. She was observed rubbing her right eye because of itchiness and discomfort in the eye. Complete resolution of the corneal edema and a central corneal scar was seen at the 6th week of follow-up. Keywords: Acute corneal hydrops; Keratoconus; Down syndrome; eyes. Early in the disease there may be no symptoms, and keratoconus Eye rubbing may be noted by the ophthalmologist simply because the patient cannot be refracted to a clear corrected vision. In advanced disease, there is Introduction significant distortion of vision accompanied by profound visual loss. Keratoconus is a condition in which the cornea assumes a conical Patients with advanced disease may occasionally present with a sudden shape as a result of noninflammatory thinning of the corneal stroma. onset of visual loss accompanied by pain. On slit lamp examination, The corneal thinning induces irregular astigmatism, myopia, and the conjunctiva may be injected and a diffuse stromal opacity may protrusion, leading to mild to marked impairment of the quality of be noted in the cornea.
    [Show full text]
  • Keratoglobus BS Wallang and S Das
    Eye (2013) 27, 1004–1012 & 2013 Macmillan Publishers Limited All rights reserved 0950-222X/13 www.nature.com/eye REVIEW Keratoglobus BS Wallang and S Das Abstract Keratoglobus is a rare noninflammatory The exact cause remains largely unknown corneal thinning disorder characterised by although various theories have been proposed generalised thinning and globular protrusion based on its similarities with other more of the cornea. It was first described as a common noninflammatory ectasia such as separate clinical entity by Verrey in 1947. Both keratoconus. In fact, these similarities have congenital and acquired forms have been brought about confusion as to whether the shown to occur, and may be associated with disorders comprising this group are separate various other ocular and systemic syndromes clinical disorders, or rather a spectrum of the including the connective tissue disorders. same disease process. Similarities have been found with other noninflammatory thinning disorders like keratoconus that has given rise to hypotheses Aetiological factors about the aetiopathogenesis. However, the exact Keratoglobus is primarily considered a genetics and pathogenesis are still unclear. congenital disorder present since birth.3–5 Clinical presentation is characterised by pro- However, in more recent years, there have been gressive diminution resulting from irregular reports of acquired forms of keratoglobus. corneal topography with increased corneal The congenital form of the disorder is always fragility due to extreme thinning. Conservative bilateral. The exact genetics of the disorder have and surgical management for visual rehabilita- not been studied in detail and no definite tion and improved tectonic stability have been inheritance pattern has been described. It is described, but remains challenging.
    [Show full text]
  • Ocular Disease Management 18Th18th Eeditiondition
    Joseph W. Sowka, OD Andrew S. Gurwood, OD Alan G. Kabat, OD Eyelids and Adnexa, PAGE 09 Conjunctiva and Sclera, PAGE 24 Corneal Disease, PAGE 35 Uvea and Glaucoma, PAGE 49 Vitreous and Retina, PAGE 66 Neuro-Ophthalmic Disease, PAGE 79 The Handbook of OCULAR DISEASE MANAGEMENT 18TH18TH EDITIONEDITION Supplement to JUNE 15, 2016 www.reviewofoptometry.com Dr. Sowka Dr. Gurwood Dr. Kabat 2016_RO_DiseaseGuide_Cover.indd 2 6/3/16 5:31 PM INDICATIONS AND USAGE ZYLET® (loteprednol etabonate 0.5% and tobramycin 0.3% ophthalmic suspension) is a topical anti-infective and corticosteroid combination for steroid-responsive infl ammatory ocular conditions for which a corticosteroid is indicated and where superfi cial bacterial ocular infection or a risk of bacterial ocular infection exists. Please see additional Indications and Usage information on adjacent page, including list of indicated organisms. RP0915_BL Zylet.indd 2 8/12/15 1:38 PM INDICATIONS AND USAGE (continued) Ocular steroids are indicated in infl ammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superfi cial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, and where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and infl ammation. They are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns, or penetration of foreign bodies. The use of a combination drug with an anti-infective component is indicated where the risk of superfi cial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye.
    [Show full text]
  • Herpes Simplex Keratitis Mimicking Acute Corneal Hydrops
    perim Ex en l & ta a l ic O p in l h t C h f Journal of Clinical & Experimental a o l m l a o n l r o g u Koo and Forster, J Clin Exp Ophthalmol 2015, 6:4 y o J Ophthalmology ISSN: 2155-9570 DOI: 10.4172/2155-9570.1000459 Case Report Open Access Herpes simplex Keratitis Mimicking Acute Corneal Hydrops Ellen H Koo* and Richard K Forster Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, USA *Corresponding author: Ellen Koo, M.D. Bascom Palmer Eye Institute, Palm Beach Gardens. 7101 Fairway Drive, Palm Beach Gardens, FL 33458, USA, Tel: 561-515-1544; E-mail: [email protected] Received date: Jul 02, 2015, Accepted date: Aug 21, 2015, Published date: Aug 25, 2015 Copyright: © 2015 Koo EH et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Purpose: The purpose of this paper is to present a case of a Herpes simplex keratitis presenting as a case of acute corneal hydrops. Methods: Case report. Results: A 57-year-old white woman presented with acute onset of pain, photophobia and decreased vision in the left eye. In the years prior, she had been under the care of her optometrist, who had previously diagnosed her with irregular astigmatism, for which she had been using rigid gas permeable contact lenses for vision correction. At the slit-lamp biomicroscope, the left eye was found to have marked corneal edema with central endothelial folds, as well as a round, paracentral area of stromal haze and opacity.
    [Show full text]
  • Slide Recognition
    Slide Recognition Group 1 Choroidal hypoplasia Optic n. coloboma Q. Abnormalities? A. Optic disc coloboma, choriodal hypoplasia Retinal detachment Optic nerve coloboma Dx - CEA Q. 6 month old dog. Describe gross abnormalities. Most likely diagnosis? A. Retinal detachment, 10x10mm bulbous protrusion from optic nerve; optic nerve coloboma with secondary retinal detachment Optic n. coloboma Retinal detachment Separation of retinal layers at junction of coloboma – vitreous dissect into subretinal space Q. Describe abnormalities. What is the pathogenesis of the retinal abnormality? A. Two foci or peripapillary hyporeflectivity (retinal detachment), 0.5 of lateral disc has grey, out of focus portion (coloboma), Rhegmatogenous retinal detachment from poor attachment of neural retina to coloboma margin. RPE coloboma RPE Q. Abnormality; anatomic location of abnormality A. Two, 0.25 disc diameter, hypo or depigmented foci; RPE (RPE “coloboma”) Ophthalmomyiasis interna Diptera Q. Most likely etiologic diagnosis; order (category) causing lesions A. Ophthalmomyiasis interna; diptera (flies). Ocular larval migrans due to nematode Surgical removal of worms + anthelmintic Q. Etiologic diagnosis; preferred treatment A. Dirofilaria immitis (in anterior chamber); surgical removal under dim light Parasitic conjunctivitis (onchocerciasis) <1mm white nodules adjacent to limbus, depigmentation, sclerosising keratitis Q. Conjunctival biopsy from a horse. Etiologic diagnosis? What ocular conditions may this etiology cause in the horse? A. Onchocerca cervicalis
    [Show full text]